HYTN Innovations Inc.
  • HYTN Innovations’ (HYTN) wholly-owned subsidiary, HYTN Cannabis Inc., has signed a sales, distribution and marketing agreement with Rose LifeScience Inc
  • The agreement allows HYTN to sell its products, through Rose, to la Société québécoise du cannabis (the SQDC)
  • Rose is a leading supplier of cannabis products in Quebec
  • HYTN formulates, manufactures, markets, and sells premium cannabis goods
  • HYTN Innovations Inc. (HYTN) opened trading at C$0.04 per share

HYTN Innovations’ (HYTN) subsidiary, HYTN Cannabis, has signed a sales, distribution and marketing agreement with Rose LifeScience Inc.

The agreement allows HYTN to sell its products, through Rose, to la Société québécoise du cannabis (the SQDC). It supports the company’s goal of delivering its consistent, natural and delicious cannabis products featuring Elevation Technology to every province and territory in Canada.

Rose is a leading supplier of cannabis products in Quebec. It ensures that consumers benefit from the responsible production, sale, and consumption of cannabis in Québec and across Canada.

HYTN notes that it has achieved vendor qualification in all Canadian markets. However, Quebec is a unique market that requires hands-on experience and on-the-ground presence.

Jason Broome, Chief Operating Officer of HYTN, commented on the news.

“Quebec is a critical market for HYTN’s cannabis beverages. Our formulations team has created unique products specifically for Quebec. We are proud that HYTN has focused on Quebec’s needs by delivering the only sugar-free maximum allowable dose, rapid onset beverage available to consumers in the province. It is a testament to our formulation, quality and operations teams that we were able to quickly scale from bench top to brite tank to meet demand.”

As per the agreement, all revenue from orders of HYTN’s cannabis products will flow from the SQDC through Rose to HYTN. The company will then pay Rose a commission for their services. 

HYTN formulates, manufactures, markets, and sells premium cannabis goods.

HYTN Innovations Inc. (HYTN) opened trading at C$0.04 per share.


More From The Market Online

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.